Journal article

Publication year: 2007

Pages: 356-359

Journal: Central European Journal of Medicine

Volume number: 2

Issue number: 3

ISSN: 1895-1058

Open access status: Hybrid

DOI Link: https://doi.org/10.2478/s11536-007-0025-3

Publisher: Springer Verlag

Abstract: 
Three weeks after the administration of intravenous methylprednisolone therapy, a 42-year-old female patient suffering from relapsinog-remitting multiple sclerosis (RR-MS) presented with a profound elevation of liver transaminases (GOT 485 U/1, GPT 1082 U/1, glutamyl transpeptidase 170 U/1). Liver biopsy revealed a profound, still active hepatitis with portal lymphocytic infiltration and fibrosis. Most likely, existing acute hepatitis was of autoinimune origin and emerged from an immune rebound phenomenon after immunosuppressive therapy. (c) Versita Warsaw and Sprinaer-Verlag Berlin Heidelberg. All rights reserved.

Harvard Citation style: Reuss, R., Retzlaff, K., Vogel, S., Franke, F. and Oschmann, P. (2007) Autoinimune hepatitis after high-dose intravenous methylprednisolone pulse in RR-MS, Central European Journal of Medicine, 2(3), pp. 356-359. https://doi.org/10.2478/s11536-007-0025-3

APA Citation style: Reuss, R., Retzlaff, K., Vogel, S., Franke, F., & Oschmann, P. (2007). Autoinimune hepatitis after high-dose intravenous methylprednisolone pulse in RR-MS. Central European Journal of Medicine. 2(3), 356-359. https://doi.org/10.2478/s11536-007-0025-3